Re-examination Study of EMEND (Aprepitant) (MK-0869-184)
Status:
Completed
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
This survey is conducted for preparing application materials for re-examination under the
Pharmaceutical Affairs Laws and its Enforcement Regulation. Its aim is to reconfirm the
clinical usefulness of EMEMD (aprepitant) through collecting the safety information according
to the Re-examination Regulation for New Drugs.